Endocrine disruptors: invisible chemicals linked to disease across populations

Spanish children are urinating plastic. That's not hyperbole—it's how physician and researcher Nicolás Olea describes the pervasive contamination of human bodies by endocrine-disrupting chemicals, invisible compounds now found in the blood of entire populations and in breast milk across the country. These substances, more than 2,000 of them identified so far, possess a troubling ability: they mimic the body's natural hormones and interfere with the systems that regulate growth, reproduction, metabolism, and development. They live in cosmetics, personal hygiene products, food packaging, and the dust of our homes. Escaping them entirely is nearly impossible.

To understand what endocrine disruptors do, think of natural hormones as messengers traveling through the bloodstream, carrying signals between organs—from ovary to breast, for instance. Endocrine disruptors are hackers of that conversation. They can block receptors, distort the transport of hormones, or warp the growth of cells that produce them. The result is a cascade of potential harms: cancer, diabetes, obesity, attention deficit hyperactivity disorder, infertility, and increasingly, the early onset of puberty. Olea, a professor at the University of Granada and physician at its teaching hospital, emphasizes that the scientific evidence is overwhelming. "The research is abundant in two areas: the mechanisms of how these contaminants interfere with hormonal receptors, and human exposure to these compounds. The evidence is more than sufficient to intervene preventively," he says. Pesticides, heavy metals, bisphenol-A, and parabens are among the most studied, but they represent only the visible portion of a much larger problem.

The true scope remains unknown. Olea suspects the 2,000 identified chemicals are merely "the tip of the iceberg." Scientists have focused their attention on estrogen, androgen, and thyroid systems, but suspicion is growing that vitamin D—which is actually a hormone—may be disrupted by chemicals whose identities remain a mystery. The gaps in knowledge are vast, and the vulnerability windows are narrow and critical. Prenatal exposure is one such window: chemicals can cross the placenta and alter a child's long-term health. A 2018 study published in JAMA Pediatrics found that prenatal exposure to certain phthalates was associated with language delays in children. The prepubescent period is another danger zone, a time when the body prepares for hormonal activation. Recent research published in Endocrinology suggests that ambrette musk, a fragrance component common in soaps, detergents, and creams, along with other synthetic musks, may be contributing to the trend of earlier puberty onset.

Martine Vrijheid, director of the Lifelong Environment and Health Program at ISGlobal, offers a measured perspective amid the gloom: the concentrations of these chemicals found in blood samples are generally very low. But she immediately qualifies that reassurance. "We need better information about the health effects, even at low exposure levels," she says. The chemicals drawing the most concern include polybrominated compounds, which are flame retardants found in synthetic products and textiles and linked to thyroid problems; phthalates and phenols, associated with infertility in adults and growth delays and ADHD in children; and PFAS—perfluorinated compounds known as "forever chemicals" because they persist indefinitely in the environment and the human body. PFAS repel water and oil, resist extreme temperatures, and have been linked to immune system damage, liver toxicity, reproductive harm, diabetes, obesity, and neurodevelopmental effects.

The challenge for scientists is that the dose-response relationship is not linear. A small increase in exposure does not necessarily produce a proportional increase in harm. Moreover, humans carry a baseline load of these chemicals already. The real danger may lie not in any single compound but in the cumulative effect of exposure to many different ones simultaneously. "We live in this chemical soup and we have very little idea what happens when you're exposed to many different endocrine disruptors at once," Vrijheid observes. A study published last May suggested that exposure to a mixture of these hormonal disruptors is associated with poor metabolic health and contributes to metabolic syndrome—obesity, diabetes, hypertension—over a lifetime.

Experts lament the lack of clear information and guidance for the public. Better labeling of products would help, Vrijheid argues, but the chemical composition of most consumer goods remains opaque. Individual actions—reducing processed foods, ventilating homes, avoiding heating plastic containers in microwaves—offer some protection, but a scientific review concluded that systemic policy changes reducing or eliminating endocrine disruptors in manufacturing across multiple sectors would have far greater impact than individual behavior change. Yet the regulatory machinery moves with glacial slowness. When one chemical is banned, industry replaces it with ten new ones, and tracking that substitution is nearly impossible. Olea offers a stark example: bisphenol-A was first identified in food can linings in 1995. It was not removed from baby bottles until 2011. The European Union will not ban it entirely until December 31, 2024. By then, countless other chemicals will have infiltrated the market, studied far too late, regulated far too slowly.